Endoscopic Measurements of Mitochondrial Oxygen Tension: a dose-finding study

Endoscopic Measurements of Mitochondrial Oxygen Tension: a dose-finding study - Endo-mitoPO2-dose-study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON44385

Enrollment

Registered

2017-11-01

Start date

2018-03-05

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic mesenteric ischemia lack of oxygen of the intestine

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * * 18 years * Informed consent * Unremarkable medical history (no gastroenterologic diseases or surgery, no cardiac or pulmonal diseases) * No gastrointestinal complaints

Exclusion criteria

Exclusion criteria: * 1.5x Upper Limit of Normal (ULN) of Alanine transaminase (ALT and/or Aspertate transaminase (AST) and/or alkaline phosphatase (ALP) and/or gamma-glutamyltransferase (GGT) and/or bilirubin)

Design outcomes

Primary

Measure	Time frame
the minimum effective dose of 5-aminolevulinic acid (Gliolan) for adequate MitoPO2 measurements during upper endoscopy	—

Countries

Netherlands

Outcome results